Mirion initiated with an Outperform at Northland

Northland initiated coverage of Mirion (MIR) with an Outperform rating and $26 price target The radiation technology company has a presence in over 95% of the current global nuclear reactor fleet and is exposed to the attractive end markets of nuclear power and nuclear medicine, the analyst tells investors. The firm believes Mirion’s mix of recurring revenue and growth upside will allow “investors to have their cake and eat it too,” the analyst added.